TCV Trust & Wealth Management
TCV Trust & Wealth Management reported 220 stocks worth $1.3B in its 13F filing for Q3 2026, filed Oct 16, 2026. Its largest holdings are AVGO (5.5%), MSFT (4.5%) and SPIB (4.2%). Compared with Q2 2026, the fund opened new positions in XOM, added to SPIB, GVI and JPM, trimmed AVGO, MSFT and AAPL and sold out of XOM, CVS and OKE.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  AVGO Broadcom Inc | $70.5M | 5.5% | 201K | −5,894 (−3%) | 8 of 8 | |
| 2 |  MSFT Microsoft Corp | $58.2M | 4.5% | 114K | −1,331 (−1%) | 8 of 8 | |
| 3 |  SPIB Spdr Series Trust | $54.4M | 4.2% | 1.7M | +61K (+4%) | 8 of 8 | |
| 4 |  AAPL Apple Inc | $51.9M | 4.0% | 156K | −3,204 (−2%) | 8 of 8 | |
| 5 |  GVI Blackrock, Inc. | $50.1M | 3.9% | 487K | +12K (+2%) | 8 of 8 | |
| 6 |  VO Vanguard Index Fds | $47.9M | 3.7% | 611K | −9,160 (−1%) | 8 of 8 | |
| 7 |  VB Vanguard Index Fds | $46.8M | 3.6% | 165K | −3,681 (−2%) | 8 of 8 | |
| 8 |  SPY Spdr S&P 500 ETF TR | $37.8M | 2.9% | 50K | −2,952 (−6%) | 8 of 8 | |
| 9 |  GLW Corning Inc | $28.2M | 2.2% | 183K | −5,064 (−3%) | 6 of 8 | |
| 10 |  JPM Jpmorgan Chase & Co. | $27.6M | 2.1% | 83K | +267 (+0%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 XOM Exxon Mobil Corp | $3.7M | 27K |
 CVS Cvs Health Corp | $597K | 5,775 |
 OKE Oneok Inc New | $274K | 3,157 |
 MKC Mccormick & Co Inc | $241K | 4,780 |
 PWR Quanta Svcs Inc | $238K | 330 |
🔒 Free account: see all 16.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →TCV Trust & Wealth Management 13F FAQ
What does TCV Trust & Wealth Management own?
TCV Trust & Wealth Management reported 220 stocks worth $1.3B in its 13F filing for Q3 2026, filed Oct 16, 2026. Its largest holdings are AVGO (5.5%), MSFT (4.5%) and SPIB (4.2%). The table above lists every position in the filing (the top 10 without an account).
What did TCV Trust & Wealth Management buy and sell in Q3 2026?
Compared with Q2 2026: 10 new positions, 56 added to, 108 trimmed and 16 sold out. New positions include XOM. It sold all of XOM, CVS and OKE.
When will TCV Trust & Wealth Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is TCV Trust & Wealth Management's portfolio worth?
The Q3 2026 filing reports $1.3B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.